Research Article
Volume 12 Issue 8 - 2020
Brain and Covid-19: An Integrative Review
Nicolle dos Santos Moraes Nunes1*, Jacqueline Stephanie Fernandes do Nascimento1, Janie Kelly Fernandes do Nascimento1, Renata Rodrigues Teixeira de Castro2, Marco Antônio Alves Azizi2, Gilberto Canedo Martins Junior3, Antônio Marcos da Silva Catharino3, Valéria Camargo Silveira3 and Marco Antônio Orsini Neves4
1Medical Student of Universidade Iguaçu, Universidade Iguaçu-UNIG-RJ, Nova Iguaçu-RJ, Brazil
2Physician, Associated Professor of Medicine of Universidade Iguaçu, Universidade Iguaçu-UNIG-RJ, Nova Iguaçu, Brazil
3Physician, Neurologist, Associated Professor of Medicine of Universidade Iguaçu, Universidade Iguaçu-UNIG-RJ, Nova Iguaçu, Brazil
4Physician, Neurologist, Post Doctor of Universidade Federal do Rio de Janeiro, Titular Professor of Medicine of Universidade Iguaçu, Universidade Iguaçu-UNIG-RJ, Nova Iguaçu-RJ, Brazil
*Corresponding Author: Nicolle dos Santos Moraes Nunes, Medical Student of Universidade Iguaçu, Universidade Iguaçu-UNIG-RJ, Nova Iguaçu-RJ, Brazil.
Received: July 11, 2020; Published: July 22, 2020


Introduction: December 2019, an outbreak of Severe Acute Respiratory Distress Syndrome started in Wuhan, China. This injury spread rapidly until, in March 2020, the World Health Organization (WHO) declared a pandemic. Although respiratory symptoms are more reported, there is also evidence of impairment of the nervous system. Among the main neurological symptoms reported, the following stand out: headache, vertigo, altered consciousness, encephalopathies, cerebrovascular disease and seizures.

Objectives: The objective of this study is to describe, based on the current literature, the main evidence of brain involvement by COVID-19 and its clinical manifestations.

Methodology: This is an integrative literature review, carried out through the following databases: PubMed, LILACS, BIREME. The searches were limited to articles from the year 2020, in English and Portuguese. For this search, were used the descriptors indexed in MESH and DeCS “BRAIN” or “CEREBRAL” or “BRAIN INJURIES” or “CENTRAL NERVOUS SYSTEM” and “COVID-19” or “SARS-CoV-2”.

Results: Through crossing of descriptors in the databases, and reverse search tools, 594 articles were found. Among these, 46 were selected to compose the sample.

Discussion: Reports were found of patients with COVID-19 who had: benign intracranial hypertension, seizures, ischemic and hemorrhagic cerebrovascular diseases, acute necrotizing encephalopathy, Birkerstaff encephalitis, meningitis, and delirium. In addition, previous studies suggest that the involvement of the central nervous system by SARS-CoV-2 may induce an increase in neurodegenerative disorders in the future.

Conclusion: It is a fact that the SARS-CoV-2 virus is capable of affecting the central nervous system. The clinical manifestations resulting from this are related to the greater severity of the condition, and a greater risk of unfavorable outcomes. Thus, it is imperative that the neurological examination of these patients is done extremely carefully, and that clinical findings are reported and not disregarded.

Keywords: Brain; COVID-19; Neurologic Manifestations


  1. Cucinotta D and Vanelli M. “WHO Declares COVID-19 a Pandemic”. Acta Biomedica 91.1 (2020): 157-160. 
  2. Montalvan V., et al. “Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review”. Clinical Neurology and Neurosurgery 194 (2020): 105921. 
  3. Li YC., et al. “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients”. Journal of Medical Virology 92.6 (2020): 552-555. 
  4. Dube M., et al. “Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43”. Journal of Virology (2018): 92. 
  5. National Health Commission of the People′s Republic of China. Diagnosis and treatment of the novel coronavirus pneumonia (2020). 
  6. Mao L., et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China”. JAMA Neurology 77.6 (2020): 683-690. 
  7. Saavedra JM. “COVID-19, Angiotensin Receptor Blockers, and the Brain”. Cellular and Molecular Neurobiology 40.5 (2020): 667-674. 
  8. Jahanshahlua L and Rezaei N. “Central Nervous System Involvement in COVID-19”. Archives of Medical Research (2020). 
  9. Tsuruta R and Oda Y. “A clinical perspective of sepsis-associated delirium”. Journal of Intensive Care Medicine 4 (2016): 18. 
  10. Kotfis K., et al. “COVID-19: Gerenciamento de delirium na UTI durante a pandemia de SARS-CoV-2”. Critical Care 24.1 (2020): 176. 
  11. Glass WG., et al. “Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice”. The Journal of Immunology173.6 (2004): 4030-4039. 
  12. Arbour N., et al. “Neuroinvasion by human respiratory coronaviruses”. Journal of Virology 74.19 (2000): 8913-8921. 
  13. Xu J., et al. “Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis”. Clinical Infectious Diseases 41.8 (2005): 1089-1096. 
  14. Ding Y., et al. “Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways”. The Journal of Pathology 203.2 (2004): 622-630. 
  15. Baig AM., et al. “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms”. ACS Chemical Neuroscience 11.7 (2020): 995-998. 
  16. Kotfis K., et al. “COVID-19: Gerenciamento de delirium na UTI durante a pandemia de SARS-CoV-2”. Critical Care 24.1 (2020): 176. 
  17. Martire S., et al. “PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases”. Mechanisms of Ageing and Development 146.148 (2015): 53-64. 
  18. Baig AM., et al. “Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms, ACS Chem”. The Journal of Neuroscience 11 (2020): 995-998. 
  19. Poyiadji N., et al. “COVID-19–associated acute Hemorrhagic necrotizing encephalopathy: CT and MRI features”. Radiology (2020): 201187. 
  20. Siamak Abdi., et al. “The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms”. Journal of the Neurological Sciences. 416 (2020): 117001. 
  21. Kotfis K., et al. “COVID-19: Gerenciamento de delirium na UTI durante a pandemia de SARS-CoV-2”. Critical Care 24.1 (2020): 176.
  22. Bergmann CC., et al. “Coronavirus infection of the central nervous system: host-virus stand-off”. Nature Reviews Microbiology 4.2 (2006): 121-132. 
  23. Pilli D., et al. “Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System”. Frontiers in Immunology 8 (2017): 652. 
  24. Maldonado JR. “Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure”. International Journal of Geriatric Psychiatry 33.11 (2018): 1428-1457. 
  25. Noro F., et al. “COVID-19 and benign intracranial hypertension: A case report”. Revista da Sociedade Brasileira de Medicina Tropical 53 (2020): e20200325. 
  26. Li B., et al. “Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”. Clinical Research in Cardiology (2020). 
  27. Poyiadji N., et al. “COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features”. Radiol Imaging (2020). 
  28. Sharifi-Razavi A., et al. “COVID 19 and Intra cerebral hemorrhage: causative or coincidental”. New Microbes and New Infections (2020). 
  29. A Sharifi-Razavi., et al. “COVID 19 and Intra cerebral hemorrhage: causative or coincidental”. New Microbes and New Infections 35 (2020): 100669.
  30. Jahanshahlua L and Rezaei N. “Central Nervous System Involvement in COVID-19”. Archives of Medical Research (2020). 
  31. Kuroda N. “Epilepsy and COVID-19: Associations and important considerations”. Epilepsy and Behavior 108 (2020): 107122. 
  32. Jacomy H and Talbot PJ. “Vacuolating encephalitis in mice infected by human coronavirus OC43”. Virology 315 (2003): 20-33. 
  33. Yoshikawa N., et al. “Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2”. Journal of Virology 83 (2009): 5451-5465. 
  34. Grist JJ., et al. “Neutrophils and viral-induced neurologic disease”. Journal of Clinical Immunology 189 (2018): 52-56. 
  35. Kotfis K., et al. “COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?”. Anaesthesiology Intensive Therapy 52.2 (2020): 132-138. 
  36. Howe CL., et al. “Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain”. Journal of Neuroinflammation 9 (2012): 50. 
  37. Mao L., et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China”. JAMA Neurology 77.6 (2020): 683-690. 
  38. Corbett JJ. "Pseudotumor Cerebri" by any other name”. Archives of ophthalmology 118.12 (2000): 1685. 
  39. A Sharifi-Razavi., et al. “COVID 19 and Intra cerebral hemorrhage: causative or coincidental”. New Microbes and New Infections 35 (2020): 100669.
  40. Umapathi T., et al. “Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)”. Journal of Neurology 251 (2004): 1227-1231. 
  41. Beyrouti R., et al. “Characteristics of ischaemic stroke associated with COVID-19”. Journal of Neurology, Neurosurgery, and Psychiatry (2020).
  42. Tang N., et al. “Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia”. Journal of Thrombosis and Haemostasis 18 (2020): 844-847.
  43. Poyiadji N., et al. “COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features”. Radiology (2020): 201187. 
  44. Saavedra JM. “COVID-19, Angiotensin Receptor Blockers, and the Brain”. Cellular and Molecular Neurobiology 40.5 (2020): 667-674. 
  45. Readhead B., et al. “Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus”. Neuron 99.1 (2018): 64-82. 
  46. Gamboa ET., et al. “Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence”. Archives of Neurology 31.4 (1974): 228-232. 
Citation: Nicolle dos Santos Moraes Nunes., et al. “Neurocysticercosis and Secondary Headache”. EC Neurology 12.8 (2020): 101-107.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 17, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to